Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Robert DeHaven who wrote (166)	11/18/1997 6:56:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 1510

Robert - I would like your opinion on something. They had cash&Equi of $15.0 at Sept. Lets say they eat $6.0+ a qtr. Is the market price foreseeing the equity offer? If they come out, it would be prudent to go for at least $25.0 mil. At $10 a pop that's 2.5 mil shares. Have you thought about any of this? Without news, I think we're going to be held in a tight trading range. If you see it different - I hope so - and please advise. Regards, John

To: Robert DeHaven who wrote (166)	11/22/1997 6:51:00 PM
From: Manny Gugliuzza	Respond to of 1510

bob, when was the last time you saw a monthly chart like imnr? nearly a perfect cup from early 96 till now. with a finishing handle in the up flag postion, it seems this pull back to the levels at the end of august was successfully completed. how organized it was also is quite appealing, drifting lower only from a real lack of buying(90 % of the up days on good volume and most of the down days on very low volume some nearly 1/10 of a. d. volume. good call on that test i never thought it would close below 10. looks like 2 x 9 11/16 and maybe as acute as september? barring any ugly fundamentals! ar